NCDR.18: Going Beyond Data Collection to Blaze New Trails
Nearly 2,000 registry professionals, quality experts, physicians and cardiovascular administrators gathered this past week for the NCDR Annual Conference (NCDR.18). With the theme, “Trailblazing the Future,” this year’s conference focused on ways the NCDR is going beyond data collection to establish a new generation of cardiovascular care by using data to guide quality improvement initiatives with the goal of improving patient care.
The conference kicked-off with the Ralph G. Brindis Keynote Lecture, delivered by Douglas B. Fridsma, MD, PhD, president and CEO of the American Medical Informatics Association. In his lecture, titled “Interoperability: A Promise Kept (or not) to Transform Healthcare,” Fridsma discussed the barriers and opportunities for streamlining data collection and presented an outline for future data interoperability.
As the health care environment increasingly focuses on value-based care, the need to analyze and apply data to care decisions continues to be a high priority within the NCDR. “NCDR plays a critical role in our ever-changing health care system,” says Ralph G. Brindis, MD, MPH, MACC, NCDR senior medical advisor. “The registries are an important linchpin for monitoring measures that are tied to value-based reimbursement and demonstrating quality in cardiovascular care.”
Throughout the meeting, attendees gained new NCDR registry-specific and industry knowledge, took away best practices through networking, and discovered tools and techniques to apply to quality improvement efforts. Registry-specific concurrent workshops throughout the conference provided participants with a deep-dive into individual registries and provided updates and opportunities to discuss data quality issues. In addition, ACTION Registry, ICD Registry, CathPCI Registry and STS/ACC TVT Registry agendas were divided into two, 40-minute sessions to allow more time for case scenarios.
“The NCDR is evolving to meet the demands of a changing health care environment,” explains ACC Vice President C. Michael Valentine, MD, FACC. “We’re looking at how to use that data to develop quality improvement innovations that will ensure we’re delivering the best possible care to patients and improving outcomes.”
Participants heard real-world examples of how NCDR participants are analyzing data to harness performance improvement and how stakeholders, such as private payers, state and federal government agencies, are using NCDR data to accelerate clinical performance.
Always a highlight of the conference, the annual awards ceremony yesterday afternoon recognized this year’s poster winners. NCDR received nearly 80 poster abstracts this year representing the eight hospital registries. Selected posters highlight how institutions have used NCDR data to inform grassroots quality improvement efforts.
The conference closed with an interactive session called “It’s NCDR Jeopardy!” Selected contestants answered questions across categories spanning each of the NCDR registries, broader areas like NCDR history and NCDR research, and quality improvement in a format similar to the game show.
For more information about NCDR.18, visit CVQuality.ACC.org.
Don’t miss today’s session, NCDR CathPCI Registry for Reporting and Quality, from 4:45 – 6:00 p.m. in Room 205 A.
NCDR Research at ACC.18
Several abstracts based on NCDR data will be presented during ACC.18. Research topics include the impact of the diabetes drug empagliflozin on cardiovascular risk factor, the effect of age and frailty on survival in patients undergoing TAVR, in-hospital mortality after TAVR, and outcomes following urgent TAVR procedures. Expanding on previous years, these abstracts highlight the role of NCDR registries in practice-changing clinical research.
ACTION Registry
- Predicting the Need For Skilled Nursing Facilities After Acute Myocardial Infarction
Jason H. Wasfy, MD, MPhil, FACC
Saturday, March 10, 10 – 10:45 a.m.
Poster Hall, Hall A/B
- Association of Pre-Activation of the Cardiac Catheterization Laboratory on Reperfusion Timing Metrics For Patients With STEMI Undergoing Primary PCI: A Report From ACTION Registry
Jay Shavadia, MB BCh
Monday, March 12, 8:51 – 9:01 a.m.
Room 205 A
- Regionalization of STEMI Care in ACTION: National and International Perspectives
James G. Jollis, MD, FACC
Monday, March 12, 1:31 – 1:40 p.m.
Room 304 E
CathPCI Registry
- Use and Effectiveness of Manual Aspiration Thrombectomy During PCI For the Treatment of STEMI in the U.S.: An Analysis From the NCDR CathPCI Registry
Eric Alexander Secemsky, MD
Saturday, March 10, 10 – 10:45 a.m.
Poster Hall, Hall A/B
- Comparison of Rates of Bleeding and Vascular Complications Before, During and After Trial Enrollment in the SAFE-PCI Trial For Women
Jennifer Rymer, MD
Saturday, March 10, 3:45 – 4:30 p.m.
Poster Hall, Hall A/B
- Current Landscape of Hybrid Revascularizations: A Report From the NCDR
Angela Lowenstern, MD
Saturday, March 10, 4:15 – 4:25 p.m.
Interventional Cardiology Moderated Poster Theater, Poster Hall, Hall A/B
- Uptake and Utilization of Drug-Eluting Bioresorbable Vascular Scaffolds: A CathPCI Registry Study
Ajay J. Kirtane, MD, FACC
Sunday, March 11, 8:38 – 8:48 a.m.
Room 204 C
- Ad Hoc PCI in Patients With Stable Coronary Artery Disease: A Report From the NCDR
Kamil Faridi, MD
Monday, March 12, 9:45 – 10:30 a.m.
Poster Hall, Hall A/B
Diabetes Collaborative Registry
- Real-World Opportunity of Empagliflozin in Cardiovascular Risk Factor Modification: An NCDR Research-to-Practice Project From the Diabetes Collaborative Registry
Suzanne Arnold, MD
Sunday, March 11, 10 – 10:10 a.m.
Prevention Moderated Poster Theater, Poster Hall, Hall A/B
- Eligibility Varies Across the 3 Sodium-Glucose Cotransporter-2 Inhibitor Cardiovascular Outcomes Trials Among Adults With Type 2 Diabetes: Implications From Analysis of the Diabetes Collaborative Registry
Eric Wittbrodt, PharmD
Sunday, March 11, 4:15 – 4:25 p.m.
Prevention Moderated Poster Theater, Poster Hall, Hall A/B
PINNACLE Registry
- Reducing Cardiovascular Risk in the Medicare Million Hearts Risk Reduction Model
William Borden, MD, FACC
Sunday, March 11, 10:15 – 10:25 a.m.
Prevention Moderated Poster Theater, Poster Hall, Hall A/B
- Guideline-Recommended Patient Education Among Outpatients With Heart Failure: Results From the NCDR PINNACLE Registry
Karl E. Minges, PhD, MPH
Monday, March 12, 10:15 – 10:25 a.m.
Prevention Moderated Poster Theater, Poster Hall, Hall A/B
- Management of Resistant Hypertension and Implications of PATHWAY-2 Trial in U.S. Cardiology Practice: Insights From NCDR PINNACLE Registry
Lauren Thompson, MD
Monday, March 12, 1:15 – 1:25 p.m.
Prevention Moderated Poster Theater, Poster Hall, Hall A/B
STS/ACC TVT Registry
- The Effect and Relationship of Age and Frailty on Survival in Patients Undergoing TAVR
Soroosh Kiani, MD
Saturday, March 10, 10 – 10:10 a.m.
Interventional Cardiology Moderated Poster Theater, Poster Hall, Hall A/B
- Outcomes After Transcatheter Mitral Valve Repair in Patients With Chronic Kidney Disease: An Analysis of 5,241 Patients in the U.S.
Binita Shah, MD, FACC
Saturday, March 10, 10 – 10:45 a.m.
Poster Hall, Hall A/B
- High Hospital Variability in Mortality After TAVR Can be Explained by Differences in Failure to Rescue From Post-Procedural Complications
Muath Bishawi, MD
Saturday, March 10, 10:30 – 10:40 a.m.
Interventional Cardiology Moderated Poster Theater, Poster Hall, Hall A/B
- Outcomes Following Urgent/Emergent TAVR: Insights From the STS/ACC TVT Registry
Dhaval Kolte, MD, PhD
Sunday, March 11, 1:15 – 1:25 p.m.
Interventional Cardiology Moderated Poster Theater, Poster Hall, Hall A/B
- Atrial Fibrillation Is Associated With Higher Rates of Death and Heart Failure Hospitalizations in Patients Undergoing MitraClip: Outcomes From the TVT Registry
Sameer Arora, MD
Monday, March 12, 9:45 – 10:30 a.m.
Poster Hall, Hall A/B
Keywords: ACC Publications, ACC Scientific Session Newspaper, ACC Annual Scientific Session
< Back to Listings